Case 24: Progressive Glioma
Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research › peer-review
The use of O-(2-[18F]fluoroethyl)-L-tyrosine ([18F]FET) PET permits a more sensitive assessment of metabolically active tumor, treatment failure, and distant non-contrast-enhancing progression in this patient with anaplastic oligodendroglioma, WHO grade III, where progression on MRI was challenged because of changing patterns of speckled new and dissolving old non-measurable contrast enhancement.
| Original language | English |
|---|---|
| Title of host publication | Clinical Nuclear Medicine in Neurology : An Atlas of Challenging Cases |
| Editors | Andrea Varrone, Silvia Morbelli, Valentina Garibotto |
| Publisher | Springer |
| Publication date | 2022 |
| Pages | 119-123 |
| Chapter | 24 |
| ISBN (Print) | 978-3-030-83597-2 |
| ISBN (Electronic) | 978-3-030-83598-9 |
| DOIs | |
| Publication status | Published - 2022 |
ID: 345057605